Page last updated: 2024-09-03

rg 14893 and sb 201993

rg 14893 has been researched along with sb 201993 in 2 studies

Compound Research Comparison

Studies
(rg 14893)
Trials
(rg 14893)
Recent Studies (post-2010)
(rg 14893)
Studies
(sb 201993)
Trials
(sb 201993)
Recent Studies (post-2010) (sb 201993)
500500

Protein Interaction Comparison

ProteinTaxonomyrg 14893 (IC50)sb 201993 (IC50)
Leukotriene B4 receptor 1Homo sapiens (human)0.131

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chambers, PA; Daines, RA; Eggleston, DS; Foley, JJ; Griswold, DE; Haltiwanger, RC; Jakas, DR; Kingsbury, WD; Martin, LD; Pendrak, I1
Chambers, PA; Daines, RA; Foley, JJ; Griswold, DE; Jakas, DR; Martin, LD; Pendrak, I; Sarau, HM; Schmidt, DB; Tzimas, MN1

Other Studies

2 other study(ies) available for rg 14893 and sb 201993

ArticleYear
(E)-3-[[[[6-(2-carboxyethenyl)-5-[[8-(4- methoxyphenyl)octyl]oxy]-2-pyridinyl]-methyl]thio]methyl]benzoic acid and related compounds: high affinity leukotriene B4 receptor antagonists.
    Journal of medicinal chemistry, 1994, Sep-30, Volume: 37, Issue:20

    Topics: Benzoates; Binding, Competitive; Calcium; Crystallography, X-Ray; Cytoplasmic Granules; Humans; Leukotriene B4; Molecular Structure; Neutrophils; Pyridines; Receptors, Leukotriene B4; Structure-Activity Relationship

1994
(E)-3-[[[[6-(2-carboxyethenyl)-5-[[8-(4- methoxyphenyl)octyl]oxy]-2-pyridinyl]-methyl]thio]methyl]benzoic acid: a novel high-affinity leukotriene B4 receptor antagonist.
    Journal of medicinal chemistry, 1993, Sep-03, Volume: 36, Issue:18

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzoates; Calcium; Humans; Inflammation; Leukotriene B4; Mice; Molecular Structure; Neutrophils; Pyridines; Receptors, Leukotriene B4

1993